HomeNewsBusinessMarketsGlenmark finds cancer drug, gains to reflect in long term
Trending Topics

Glenmark finds cancer drug, gains to reflect in long term

Shares of Glenmark Pharmaceuticals rose nearly 2.5% on Thursday after the pharma giant announced discovery of a blood cancer drug GBR 401, which falls under biologic category of medicines. Athough discovery of the drug is a positive development, its impact on the company’s financials is a long term story, analysts said.

March 31, 2011 / 13:21 IST
Story continues below Advertisement

Shares of Glenmark Pharmaceuticals rose nearly 3% on Thursday after the pharma giant announced discovery of a blood cancer drug GBR 401, which falls under biologic category of medicines. Athough discovery of the drug is a positive development, its impact on the company

first published: Mar 31, 2011 11:48 am

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!